Search results
Please send general questions related to the drug data in these files to the Center for Drug Evaluation and Research, Division of Drug Information: druginfo@fda.hhs.gov. Current through...
Oct 13, 2023 · FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) identifies drug products approved on the basis of safety and effectiveness.
Mar 8, 2023 · Downloadable Data Files for the Orange Book. The compressed (.ZIP) data file unzips into three files, whose field descriptions appear below. All three files are in ASCII text, tilde (~)...
Preface to Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) provides info on how the book came to be, relevant terms and codes, user responsibilities and more.
Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, is a publication produced by the United States Food and Drug Administration (FDA), as required by the Drug Price and Competition Act (Hatch-Waxman Act).
Jun 1, 2020 · In 1985, FDA added to the Orange Book a list of OTC drug products that have been approved in NDAs or ANDAs. In 1997, FDA published the Orange Book on the internet. In 2003, FDA started publishing an indicator as to whether a listed patent contains drug substance and/or drug product claims.
The Orange Book is composed of four parts: (1) approved prescription drug products with therapeutic equivalence evaluations; (2) approved over-the-counter (OTC) drug products for those drugs that may not be marketed
require the submission of a request to remove patent information from the Orange Book are submitted to FDA at the time of approval of the supplement pursuant to 21 CFR 314.53(d)(2)(ii)(B) and 314.53(f)(2)(iv). METHODS VALIDATION . We have not completed validation of the regulatory methods. However, we expect your continued cooperation to resolve any problems that may be identified.
The FDA's Orange Book identifies approved drug products. FDA has draft guidance explaining that certain currently marketed drug ingredients were marketed before current FDA legislation....
07/08/2021 Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations 1/ Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations Mkt.Status Active Ingredient Proprietary Name Appl. No. Dosage Form Route Strength TE Code RLD RS Applicant Holder RX FOMEPIZOLE FOMEPIZOLE A078368 INJECTABLE INJECTION 1.5GM/1.5ML (1GM/ML) AP AMERICAN REGENT INC RX FOMEPIZOLE FOMEPIZOLE A078639 INJECTABLE INJECTION 1.5GM/1.5ML (1GM/ML)
